Disability Benefits for Bullous Disease

How SSA Evaluates Bullous Disease

Bullous diseases are a group of conditions in which large fluid-filled blisters (bullae) form on the skin and mucous membranes. They include pemphigus, bullous pemphigoid, dermatitis herpetiformis, and epidermolysis bullosa. When widespread, the blisters rupture into raw, painful erosions that are slow to heal and prone to infection, and some forms can be life-threatening. The Social Security Administration evaluates them under Blue Book listing 8.03, bullous disease.

Listing 8.03 has a single, clear requirement:

• Extensive skin lesions — blistering that is very serious, affects multiple body sites, or affects sites that seriously limit the use of more than one part of the body;
• that persist for at least three months despite continuing prescribed treatment.

The three-month, treatment-resistant standard is the crux: many bullous diseases respond, at least partly, to steroids and immunosuppressants, so SSA is looking for disease that continues to produce extensive lesions despite ongoing therapy. Lesions in critical areas — the hands, feet, or skin folds, or across large surfaces — can limit movement, walking, and the use of the hands. Because the powerful medications used to control these diseases carry significant side effects, SSA considers those effects too, and the impairment must last, or be expected to last, at least 12 months.

Medical Evidence SSA Needs for Bullous Disease

Dermatology records are the core of the claim. SSA needs a confirmed diagnosis — typically supported by a skin biopsy with direct immunofluorescence, and sometimes blood antibody testing — along with clinical notes describing the extent, location, and severity of the blistering and erosions at each visit, and how they limit movement and the use of affected body parts. Clinical photographs are highly persuasive.

Proof of treatment resistance over at least three months is essential: records of corticosteroids, immunosuppressants, biologic therapy, and wound care, and your ongoing response, showing that extensive lesions persisted despite treatment.

Document complications and side effects too — skin infections, the effects of long-term steroids (bone loss, high blood sugar, weight change), pain, and any hospitalizations — since these deepen the functional picture SSA must weigh.

Qualifying Through Your Residual Functional Capacity

Bullous disease that falls short of the listing's extent requirement can still prevent work, and the residual functional capacity stage addresses it. Painful erosions on the hands limit handling, fingering, and gripping; lesions on the feet make standing and walking difficult; and blistering aggravated by pressure or friction restricts sitting, lifting, and repetitive movement. Because the skin breaks down with mechanical stress, many physical job demands are simply not tolerable.

The open, weeping lesions create a genuine infection risk and require ongoing wound care, producing absences and time off task, and they make certain work environments unsafe or impractical. The medications used to control the disease add their own limits: long-term steroids cause fatigue, weakness, and other systemic effects, while immunosuppressants raise infection risk. Chronic pain and the medications for it reduce concentration.

For claimants 50 and older, a sedentary RFC combined with the medical-vocational grid rules often supports approval. Younger claimants generally need to show that pain, flares, wound care, and medication effects preclude even sedentary work.

Tips for a Stronger Bullous Disease Claim

Document extent, persistence, and the effects of treatment.

• Make sure the diagnosis is confirmed by biopsy and that your dermatologist records the extent and location of lesions at each visit.
• Provide dated photographs of active blistering and erosions.
• Show that extensive lesions persisted despite at least three months of prescribed treatment — the key to listing 8.03.
• Report how lesions on your hands and feet limit gripping, standing, and walking.
• Document medication side effects, especially from long-term steroids, which are limiting in their own right.